Belgian finance regulator issues warning about Hyloris Pharmaceuticals

Hyloris Pharmaceuticals SA

05/07/2024 20:02

* 
      Hyloris CEO: 'surprised' at reaction from FSMA
    

        * 
      FSMA says it has doubts over company's information to
market
    

  
       BRUSSELS, July 5 (Reuters) - Belgium's FSMA financial
regulator issued a warning to the market on Friday regarding
Hyloris Pharmaceuticals  HYL.BR , saying it had doubts over the
financial information issued to the market by Hyloris.
    The FSMA said its warning related to how Hyloris had
evaluated one of its recent licences.
    Asked to comment on the FSMA's warning notice, Hyloris CEO
Stijn Van Rompay told Reuters: "I am extremely surprised by this
turn of events."
    He said the company aimed to issue an update on its
situation to investors.
    Hyloris has a current stock market capitalisation of around
330 million euros ($357.5 million).
    ($1 = 0.9232 euros)

 (Reporting by Sudip Kar-Gupta. Editing by Jane Merriman)
 ((sudip.kargupta@thomsonreuters.com;))